P809: BASELINE CHARACTERISTICS IDENTIFYING PATIENTS WITH MULTIPLE MYELOMA TREATED WITH IDECABTAGENE VICELEUCEL (IDE-CEL; BB2121) WHO ARE AT RISK FOR SEVERE/REFRACTORY INFLAMMATORY...

por Mashadi-Hossein, Afshin, Rytlewski, Julie, Shamsuzzaman, MD, Basudhar, Debashree, Takhar, Mandeep, Kostic, Ana, Campbell, Timothy B., Manier, Salomon, Lin, Yi, Martin, Nathan
Publicado 2023

Role of nitric oxide in pancreatic cancer cells exhibiting the invasive phenotype

por Fujita, Mayumi, Somasundaram, Veena, Basudhar, Debashree, Cheng, Robert Y.S., Ridnour, Lisa A., Higuchi, Harumi, Imadome, Kaori, No, Jae Hong, Bharadwaj, Gaurav, Wink, David A.
Publicado 2019

Inducible nitric oxide synthase-derived extracellular nitric oxide flux regulates proinflammatory responses at the single cell level

por Somasundaram, Veena, Gilmore, Anne C., Basudhar, Debashree, Palmieri, Erika Mariana, Scheiblin, David A., Heinz, William F., Cheng, Robert.Y.S., Ridnour, Lisa A., Altan-Bonnet, Grégoire, Lockett, Stephen J., McVicar, Daniel W., Wink, David A.
Publicado 2019

Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer

por Basudhar, Debashree, Glynn, Sharon A., Greer, Madison, Somasundaram, Veena, No, Jae Hong, Scheiblin, David A., Garrido, Pablo, Heinz, William F., Ryan, Aideen E., Weiss, Jonathan M., Cheng, Robert Y. S., Ridnour, Lisa A., Lockett, Stephen J., McVicar, Daniel W., Ambs, Stefan, Wink, David A.
Publicado 2017

P871: IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS WITH AN INADEQUATE RESPONSE TO FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): RESULTS FROM KARMMA-2 COHORT 2C

por Alsina, Melissa, Dhodapkar, Madhav, Berdeja, Jesus, Patel, Krina, Richard, Shambavi, Vij, Ravi, Leleu, Xavier, Egan, Daniel, Leif Bergsagel, P., Ran, Reshef, Usmani, Saad Z, Truppel-Hartmann, Anna, Basudhar, Debashree, Thompson, Ethan, Zheng, Xirong, Zhong, Xiaobo, Greggio, Chiara, Popa Mckiver, Mihaela, Carrasco Alfonso, Marlene, Siegel, David
Publicado 2023